These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19645835)
1. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. Sakuma M; Setoguchi A; Endo Y J Vet Intern Med; 2009; 23(3):493-8. PubMed ID: 19645835 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs. Kirk SK; Levy JK; Crawford PC J Vet Intern Med; 2017 Jul; 31(4):1108-1112. PubMed ID: 28625019 [TBL] [Abstract][Full Text] [Related]
3. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs. Iguchi A; Matsuu A; Fujii Y; Ikadai H; Hikasa Y Vet Parasitol; 2013 Nov; 197(3-4):527-33. PubMed ID: 24075418 [TBL] [Abstract][Full Text] [Related]
4. Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin. Di Cicco MF; Downey ME; Beeler E; Marr H; Cyrog P; Kidd L; Diniz PP; Cohn LA; Birkenheuer AJ Vet Parasitol; 2012 Jun; 187(1-2):23-7. PubMed ID: 22305297 [TBL] [Abstract][Full Text] [Related]
5. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy. Jefferies R; Ryan UM; Jardine J; Robertson ID; Irwin PJ Exp Parasitol; 2007 Oct; 117(2):115-23. PubMed ID: 17543304 [TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiological survey of the Babesia gibsoni cytochrome b gene in western Japan. Sakuma M; Fukuda K; Takayama K; Kobayashi Y; Shimokawa Miyama T; Setoguchi A; Endo Y J Vet Med Sci; 2012 Oct; 74(10):1341-4. PubMed ID: 22672842 [TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316 [TBL] [Abstract][Full Text] [Related]
8. Short report: cloning of the Babesia gibsoni cytochrome B gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment. Matsuu A; Miyamoto K; Ikadai H; Okano S; Higuchi S Am J Trop Med Hyg; 2006 Apr; 74(4):593-7. PubMed ID: 16606990 [TBL] [Abstract][Full Text] [Related]
9. The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni. Lin EC; Chueh LL; Lin CN; Hsieh LE; Su BL Vet Parasitol; 2012 May; 186(3-4):159-64. PubMed ID: 22222008 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Matsuu A; Koshida Y; Kawahara M; Inoue K; Ikadai H; Hikasa Y; Okano S; Higuchi S Vet Parasitol; 2004 Sep; 124(1-2):9-18. PubMed ID: 15350657 [TBL] [Abstract][Full Text] [Related]
11. A SimpleProbe(®) real-time PCR assay for differentiating the cytochrome b M121I mutation in clinical specimens from dogs infected with Babesia gibsoni. Liu PC; Lin YL; Lin CN; Su BL Ticks Tick Borne Dis; 2016 Jul; 7(5):639-643. PubMed ID: 26874668 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of Babesia gibsoni infection from a pit-bull terrier pup recently imported into South Africa. Matjila PT; Penzhorn BL; Leisewitz AL; Bhoora R; Barker R J S Afr Vet Assoc; 2007 Mar; 78(1):2-5. PubMed ID: 17665757 [TBL] [Abstract][Full Text] [Related]
13. Development of in vitro atovaquone-resistant Babesia gibsoni with a single-nucleotide polymorphism in cytb. Iguchi A; Matsuu A; Ikadai H; Talukder MH; Hikasa Y Vet Parasitol; 2012 Apr; 185(2-4):145-50. PubMed ID: 21996003 [TBL] [Abstract][Full Text] [Related]
14. First molecular identification of Babesia gibsoni in dogs from Slovakia, central Europe. Víchová B; Horská M; Blaňarová L; Švihran M; Andersson M; Peťko B Ticks Tick Borne Dis; 2016 Feb; 7(1):54-59. PubMed ID: 26304014 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. Birkenheuer AJ; Levy MG; Breitschwerdt EB J Vet Intern Med; 2004; 18(4):494-8. PubMed ID: 15320586 [TBL] [Abstract][Full Text] [Related]
16. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477 [TBL] [Abstract][Full Text] [Related]
17. Antiprotozoal treatment of canine babesiosis. Baneth G Vet Parasitol; 2018 Apr; 254():58-63. PubMed ID: 29657012 [TBL] [Abstract][Full Text] [Related]
18. The epidemiological survey for atovaquone resistant related gene of Babesia gibsoni in Japan. Iguchi A; Soma T; Suzuki H; Xuan X J Vet Med Sci; 2016 Mar; 78(3):489-91. PubMed ID: 26549436 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Genetic Diversity of cytb gene from Babesia gibsoni Isolates from Naturally Infected Dogs in Karnataka, India. Vijaykumar LK; Chikkachowdappa PG; Venkatappa MH; Gowda AKJ; Jacob SS; Mani S; Bayyappa MRG Acta Parasitol; 2024 Mar; 69(1):375-383. PubMed ID: 38133744 [TBL] [Abstract][Full Text] [Related]
20. Resolution of a proteinuric nephropathy associated with Babesia gibsoni infection in a dog. Slade DJ; Lees GE; Berridge BR; Clubb FJ; Kuczynski LA; Littman MP J Am Anim Hosp Assoc; 2011; 47(6):e138-44. PubMed ID: 22058361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]